QA: Accustem Sciences Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001850767_2023_Accustem_Sciences_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001850767, Accustem Sciences Inc

  xvar xval
0 AssetsCurrent 932,011
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 7,678
3 remainder_Assets 0
4 LiabilitiesCurrent 1,079,239
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 3,479,486
9 ResearchAndDevelopmentExpense 266,933
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 939,689
1 Liabilities 1,079,239
2 Expenses 3,746,419
3 Revenues 0
4 StockholdersEquity -139,550
5 NetIncome -3,746,419
6 ComprehensiveNetIncome -3,746,419
7 BaseVar 2,882,674
8 EconomicCapitalRatiobeforeLimitedLiability -4.01
9 EconomicCapitalRatio 0.389

Edgar->Model Mapping

Feature Distribution